BRIEF published on 12/19/2024 at 14:35, 1 year 5 months ago Favo Capital Initiates Listing Process on Nasdaq Stock Exchange Investment Opportunities Nasdaq Listing Alternative Financing Private Credit FAVO Capital
BRIEF published on 12/19/2024 at 14:35, 1 year 5 months ago Favo Capital lance le processus d'introduction en bourse du Nasdaq Opportunités D'investissement Financement Alternatif Crédit Privé FAVO Capital Cotation Au Nasdaq
BRIEF published on 12/19/2024 at 14:20, 1 year 5 months ago ZenaTech Advances US Defense Efforts with New Arizona Facility Manufacturing Quantum Computing Defense Drones ZenaTech
BRIEF published on 12/19/2024 at 14:20, 1 year 5 months ago ZenaTech renforce les efforts de défense des États-Unis avec une nouvelle installation en Arizona Fabrication Defense Drones Informatique Quantique ZenaTech
BRIEF published on 12/19/2024 at 14:05, 1 year 5 months ago Mainz Biomed Partners with Quest Diagnostics for Cancer Screening Trial FDA Approval Clinical Trials Colorectal Cancer Diagnostic Services Healthcare Partnership
BRIEF published on 12/19/2024 at 14:05, 1 year 5 months ago Mainz Biomed s'associe à Quest Diagnostics pour un essai de dépistage du cancer Essais Cliniques Cancer Colorectal Approbation De La FDA Partenariat En Matière De Santé Services De Diagnostic
BRIEF published on 12/19/2024 at 14:05, 1 year 5 months ago Thyssenkrupp nucera Partners with Chlorum Solutions for Arizona Plant Arizona Thyssenkrupp Nucera Supply Chain Resilience Chlorum Solutions Chlor-alkali Plant
BRIEF published on 12/19/2024 at 14:05, 1 year 5 months ago Thyssenkrupp Nucera s'associe à Chlorum Solutions pour l'usine d'Arizona Arizona Thyssenkrupp Nucera Solutions De Chlore Usine De Chlore-alcali Résilience De La Chaîne D'approvisionnement
BRIEF published on 12/19/2024 at 14:05, 1 year 5 months ago IOmx Therapeutics Advances IOMX-0675 with Clinical Trial Application Cancer Treatment Clinical Trial Application IOmx Therapeutics IOMX-0675 Immunosuppressive Receptors
BRIEF published on 12/19/2024 at 14:05, 1 year 5 months ago IOmx Therapeutics fait progresser IOMX-0675 avec une application d'essai clinique Traitement Du Cancer Thérapeutique IOmx IOMX-0675 Demande D'essai Clinique Récepteurs Immunosuppresseurs
Published on 06/10/2026 at 14:30, 3 hours 40 minutes ago Agassi Sports Entertainment Signs Tennis Coaching Icon Darren Cahill to Expand Global Coaching, Content and Technology Initiatives
Published on 06/10/2026 at 14:30, 3 hours 40 minutes ago Ondas to Launch LADOS, a Layered Autonomous Defense Operational C2 Layer, at Eurosatory 2026
Published on 06/10/2026 at 13:00, 5 hours 10 minutes ago Galway Metals Reports 5.0 g/t Gold over 10.85 Metres at North Deposit and Continues to Intersect Gold in Northern Extension
Published on 06/10/2026 at 13:00, 5 hours 10 minutes ago Jaguar Mining Inc. Accelerates 5-Year Exploration Plan with Tier 1 Drilling Partnerships
Published on 06/10/2026 at 17:20, 49 minutes ago TOUGHBOOK GUARD SETS NEW STANDARDS FOR HARDWARE-BASED ENDPOINT SECURITY
Published on 06/10/2026 at 17:10, 59 minutes ago FP Markets: AI remains centre stage as London Tech Week opens its doors
Published on 06/10/2026 at 17:05, 1 hour 4 minutes ago TeamViewer Named a Leader in the Gartner® Magic Quadrant™ for Digital Employee Experience (DEX) Management Tools 2026 for the Third Consecutive Year
Published on 06/10/2026 at 17:45, 25 minutes ago Innelec : Résultats annuels 2025/26. Forte amélioration de la rentabilité opérationnelle.
Published on 06/10/2026 at 17:40, 30 minutes ago Déclaration des transactions sur actions propres réalisées du 3 au 9 juin 2026
